chr1-55047848-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001407240.1(PCSK9):​c.646+1202C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.147 in 152,136 control chromosomes in the GnomAD database, including 2,015 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 2015 hom., cov: 32)

Consequence

PCSK9
NM_001407240.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.539

Publications

7 publications found
Variant links:
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.2 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001407240.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
NM_174936.4
MANE Select
c.523+1202C>G
intron
N/ANP_777596.2
PCSK9
NM_001407240.1
c.646+1202C>G
intron
N/ANP_001394169.1
PCSK9
NM_001407241.1
c.523+1202C>G
intron
N/ANP_001394170.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
ENST00000302118.5
TSL:1 MANE Select
c.523+1202C>G
intron
N/AENSP00000303208.5
PCSK9
ENST00000710286.1
c.880+1202C>G
intron
N/AENSP00000518176.1
PCSK9
ENST00000713786.1
c.646+1202C>G
intron
N/AENSP00000519088.1

Frequencies

GnomAD3 genomes
AF:
0.147
AC:
22289
AN:
152018
Hom.:
2014
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0661
Gnomad AMI
AF:
0.175
Gnomad AMR
AF:
0.150
Gnomad ASJ
AF:
0.175
Gnomad EAS
AF:
0.00212
Gnomad SAS
AF:
0.138
Gnomad FIN
AF:
0.150
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.203
Gnomad OTH
AF:
0.171
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.147
AC:
22294
AN:
152136
Hom.:
2015
Cov.:
32
AF XY:
0.144
AC XY:
10733
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.0660
AC:
2741
AN:
41508
American (AMR)
AF:
0.149
AC:
2284
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.175
AC:
606
AN:
3470
East Asian (EAS)
AF:
0.00232
AC:
12
AN:
5168
South Asian (SAS)
AF:
0.139
AC:
667
AN:
4814
European-Finnish (FIN)
AF:
0.150
AC:
1591
AN:
10596
Middle Eastern (MID)
AF:
0.224
AC:
66
AN:
294
European-Non Finnish (NFE)
AF:
0.203
AC:
13812
AN:
67970
Other (OTH)
AF:
0.168
AC:
355
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
937
1874
2812
3749
4686
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
254
508
762
1016
1270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.113
Hom.:
211
Bravo
AF:
0.142
Asia WGS
AF:
0.0610
AC:
213
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
3.1
DANN
Benign
0.64
PhyloP100
0.54
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs529787; hg19: chr1-55513521; API